|
Prophylactic RhCE and Kell antigen matching: impact on alloimmunization in transfusion-dependent patients with myelodysplastic syndromes
|
Jan 2017
|
Vox Sang
|
myelodysplastic syndromes (MDS)
|
|
Methylation of the p73 gene in patients with myelodysplastic syndromes: correlations with apoptosis and prognosis
|
Sep 2012
|
Tumour Biol
|
myelodysplastic syndromes (MDS)
|
|
Where There's Smoke, There's Fire: Inflammation Drives MDS
|
Jul 2020
|
Trends in immunology
|
myelodysplastic syndromes (MDS)
|
|
Epigenetic Aging and Hematopoietic Cell Transplantation in Patients With Severe Aplastic Anemia
|
Apr 2021
|
Transplantation and Cellular Therapy
|
aplastic anemia, graft versus host disease (GVHD)
|
|
Transplant Referral Patterns for Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia at Academic and Community Sites in the Connect® Myeloid Disease Registry: Potential Barriers to Care
|
Apr 2023
|
Transplantation and Cellular Therapy
|
myelodysplastic syndromes (MDS)
|
|
Contribution of Revised International Prognostic Scoring System Cytogenetics to Predict Outcome After Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes: A Study From the French Society of Bone Marrow Transplantation and Cellular Therapy
|
Mar 2015
|
Transplantation
|
myelodysplastic syndromes (MDS)
|
|
Epidemiology and risk factors for infections in myelodysplastic syndromes.
|
Sep 2013
|
Transpl Infect Dis
|
myelodysplastic syndromes (MDS)
|
|
Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy.
|
Jun 2013
|
Transl Res
|
aplastic anemia
|
|
Anti-Complement Treatment in Paroxysmal Nocturnal Hemoglobinuria: Where we Stand and Where we are Going
|
Feb 2014
|
Transl Med UniSa
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Immunological derangement in hypocellular myelodysplastic syndromes
|
Feb 2014
|
Transl Med UniSa
|
myelodysplastic syndromes (MDS)
|
